Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.

Citation
Arora S, O'Brien C, Zeuzem S, et al. Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life. J Gastroenterol Hepatol 2006 Feb;21(2):406-12.
Link
http://www.ncbi.nlm.nih.gov/pubmed/16509866
Principal Investigator
Arora, Sanjeev
Project Name
Project ECHO: Extension for Community Healthcare Outcomes
Technology
Clinical Information System
Internet
Telehealth/Telemedicine
Document Type
Journal Publication
Population
Adults
Low Income Populations
Medically Underserved Populations
Medical Condition
Hepatitis
Research Method
Randomized Controlled Trial (RCT)